Editorial (1985). Feverfew—a new drug or an old wives' remedy?Lancet , i, 1084.
4.
Fisher, P.E., Silk, D.B.A., Menzies-Gow, N. & Dingle, M. (1985). Ergotamine abuse and extra-hepatic portal hypertension . Postgrad. Med. J., 61, 461-463.
5.
Greene, R. (1959). Migraine. Br. Med. J., i, 574-575.
6.
Heptinstall, S., White, A., Williamson, L. & Mitchell, J.R.A. (1985). Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet, i, 1071-1073.
7.
Johnson, S. (1984). Feverfew. London: Sheldon Press.
8.
Mintz, U., Bar-Meir, S., De Vries, A. (1974). Ergotamine-induced venous thrombosis. Postgrad. Med. J., 50, 244-246.
9.
Report (1985). Young females at risk of reaction to metoclopramide. Pharm. J., 234, 620.
10.
Richardson, P.D.I. & Withrington, P.G. (1977). The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog. Br. J. Pharmacol. , 59, 293-301.
11.
Wilkinson, M. (1984). Adverse drug reactions to drugs used in the treatment of migraine. Adverse Drug Reaction Bull., No. 108, 400-403.
